Guardion Health Sciences, Inc. (GHSI) News
Filter GHSI News Items
GHSI News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
GHSI News Highlights
- 500 - Internal server error
- Over the past 12 days, the trend for GHSI's stories per day has been choppy and unclear. It has oscillated between 2 and 8.
- The most mentioned tickers in articles about GHSI are RAMP.
Latest GHSI News From Around the Web
Below are the latest news stories about Guardion Health Sciences Inc that investors may wish to consider to help them evaluate GHSI as an investment opportunity.
Guardion Health Sciences to Be Added to the Russell 3000 IndexSAN DIEGO, June 14, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (Guardion or the Company), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements, medical foods and medical devices, today announced that Guardion is being added to the Russell 3000 Index. The inclusion of Guardion in the Russell 3000 Index will take place at the conclusion of the 2021 Russell Indexes annual reconstitution, which is expected to be effective after the U.S. market opens on June 28, 2021, according to a preliminary list of additions posted on June 4, 2021. |
Guardion Health Sciences Announces Appointment of Craig J. Sheehan as Chief Commercial OfficerProven Leader of Viactiv Brand to Oversee Ramp Up and Commercial Activities at Guardion Proven Leader of Viactiv Brand to Oversee Ramp Up and Commercial Activities at Guardion |
Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv® Product Line, from Adare PharmaceuticalsAcquisition to Transform and Strengthen Guardions Clinical Nutrition Product Portfolio |
Guardion Health Sciences to Present at the LD Micro Virtual Invitational Conference on June 9, 2021SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition and diagnostics company that develops clinically supported nutrition, supplements, medical foods, and medical devices, announced today that Chief Executive Officer Bret Scholtes will present a corporate overview at the three-day LD Micro Virtual Invitational Conference being held on June 8 10, 2021. |
Guardion Health Sciences Broadens Clinical Nutrition Product Offerings by Closing Acquisition of Activ Nutritional, which owns the Science Backed, Revenue-Generating Viactiv Product Line, from Adare PharmaceuticalsAcquisition to Transform and Strengthen Guardions Clinical Nutrition Product Portfolio Guardion Will Continue to Explore Additional Growth Opportunities to Further Expand its Presence in the Clinical Nutrition Market SAN DIEGO, June 02, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (Guardion or the Company), a clinical nutrition and diagnostics company |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayWe're kicking off another exciting week of trading with a look at the biggest pre-market stock movers for Monday morning. |
Guardion Health Sciences to Acquire Activ Nutritional, LLC and Its Well-Known Viactiv® Brand of Products from Adare Pharmaceuticals, Inc.Acquisition to Transform and Strengthen Guardions Clinical Nutrition Product Portfolio |
Guardion Health Sciences to Acquire Activ Nutritional, LLC and Its Well-Known Viactiv Brand of Products from Adare Pharmaceuticals, Inc.Acquisition to Transform and Strengthen Guardions Clinical Nutrition Product Portfolio Guardion Will Continue to Explore Additional Growth Opportunities to Further Expand its Presence in the Clinical Nutrition Market SAN DIEGO, May 18, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (Guardion or the Company), a clinical nutrition and diagnostics company |
Guardion Health Sciences Announces Financial Results for the Three Months Ended March 31, 2021Company Provides Corporate Update and Overview of Growth PlansSAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutrition, medical foods, supplements and medical devices, announced financial results for the three months ended March 31, 2021 and is also providing a corporate update for shareholders. Effective March 1, 2021, the Company effectuated a 1-for-6 reverse split of its outstanding common stock. Accordingly, all share and per share amounts included herein have been retroactively adjusted to reflect the reverse stock split for all periods presented. Financial highlights for the quarter ended March 31, 2021 include the following: Tot... |
Guardion Health Sciences to Participate in Maxim Group’s Inaugural Emerging Growth Virtual ConferenceSAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition and diagnostics company that develops clinically supported nutritional supplements, medical foods, and medical devices, announced that CEO Bret Scholtes will present at Maxim Group’s Inaugural Emerging Growth Virtual Conference to be held March 17-18, 2021. Investors can view Mr. Scholtes’s general corporate presentation once they register for the conference here, and an archived replay of the presentation will be available on the conference website. Investors can also request a 1x1 meeting with Mr. Scholtes to be arranged following the conclusion of the conference. About Guardion Health Sciences, Inc. Guardion Health Sciences, Inc. (NASDAQ: GHS... |